about
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, an...
Read More
6.94
-0.04
(-0.57%)
550.3K
XNAS Volume
XNAS 26 Sep, 2025 5:30 PM (EDT)
Medium Financial Strength
Mid Valuation
Technically Bearish
Slowing Down Stock
These stocks score good in Quality and also have medium range financials. However, a bad technical scoring and bearish aspects decrease the investor's interest over time.
View Similar
Embed DVM
Mimedx Group Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..